These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21749444)

  • 1. Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach.
    Gupta AK; Prieto-Merino D; Dahlöf B; Sever PS; Poulter NR;
    Diabet Med; 2011 Aug; 28(8):941-7. PubMed ID: 21749444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
    Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
    Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
    J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
    Haffner SM
    Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.
    Cameron AJ; Magliano DJ; Zimmet PZ; Welborn TA; Colagiuri S; Tonkin AM; Shaw JE
    J Intern Med; 2008 Aug; 264(2):177-86. PubMed ID: 18298479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism in patients with essential hypertension.
    García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
    Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of insulin resistance in the obese with metabolic syndrome.
    Manu P; Tsang J; Napolitano BA; Lesser ML; Correll CU
    Eur J Intern Med; 2010 Oct; 21(5):409-13. PubMed ID: 20816595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
    Hadaegh F; Zabetian A; Harati H; Azizi F
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men.
    Nakanishi N; Takatorige T; Fukuda H; Shirai K; Li W; Okamoto M; Yoshida H; Matsuo Y; Suzuki K; Tatara K
    Diabetes Res Clin Pract; 2004 Apr; 64(1):59-70. PubMed ID: 15036828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of age and body mass index on the metabolic syndrome and its components.
    Alexander CM; Landsman PB; Grundy SM
    Diabetes Obes Metab; 2008 Mar; 10(3):246-50. PubMed ID: 18269640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.
    Maison P; Balkau B; Souberbielle JC; Cunin P; Vol S; Macquin-Mavier I; Eschwège E;
    Diabet Med; 2007 Sep; 24(9):1012-8. PubMed ID: 17535291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating mixed hyperlipidaemia.
    Viljoen A; Wierzbicki AS
    BMJ; 2011 Aug; 343():d5146. PubMed ID: 21868456
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.